Search
for
Sort by
Research 691–720 of 1000+
- 5α‐Reductase Isozymes and Androgen Actions in the Prostate
- Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial
- Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?
- The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Prostate cancer prevention
- Prostate Cancer Early Detection, Version 2.2015
- Androgen Receptors and Androgen-Dependent Initiation of Protein Synthesis in the Prostate
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer
- Male pattern baldness and the risk of prostate cancer
- Androgen Receptor Gene Polymorphism and Prostate Zonal Volumes in Australian and Chinese Men
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- Finasteride-its impact on sexual function and prostate cancer
- Prevention and treatment of experimental prostate cancer in lobund-wistar rats. I. Effects of estradiol, dihydrotestosterone, and castration
- Baldness, benign prostate hyperplasia, prostate cancer and androgen levels
- Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer
- Hormonal prevention of prostate cancer
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
- Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century
- The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels
- Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study
- Age-Dependent Associations between Androgenetic Alopecia and Prostate Cancer Risk
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates